Patents Represented by Attorney Saliwanchik, Lloyd & Eisenschenk
  • Patent number: 8305285
    Abstract: Disclosed herein is a wireless communication module, wherein a module substrate provided with components of a communication circuit part for the wireless communication module and having a ground pattern and a power feeding pattern is provided thereon with a shield can type antenna, the shield can type antenna comprises a ground area, a plurality of curved parts formed by downwardly curving both up/down and left/right side surfaces of the ground area, and an antenna part provided at the outer side of the curved part formed at both left/right side surfaces of the ground area.
    Type: Grant
    Filed: August 19, 2010
    Date of Patent: November 6, 2012
    Assignee: LG Innotek Co., Ltd.
    Inventor: Jinsik Lee
  • Patent number: 8304728
    Abstract: Embodiments of the subject invention relate to a method and apparatus for infrared (IR) detection. Organic layers can be utilized to produce a phototransistor for the detection of IR radiation. The wavelength range of the IR detector can be modified by incorporating materials sensitive to photons of different wavelengths. Quantum dots of materials sensitive to photons of different wavelengths than the host organic material of the absorbing layer of the phototransistor can be incorporated into the absorbing layer so as to enhance the absorption of photons having wavelengths associated with the material of the quantum dots. A photoconductor structure can be used instead of a phototransistor. The photoconductor can incorporate PbSe or PbS quantum dots. The photoconductor can incorporate organic materials and part of an OLED structure. A detected IR image can be displayed to a user. Organic materials can be used to create an organic light-emitting device.
    Type: Grant
    Filed: October 22, 2010
    Date of Patent: November 6, 2012
    Assignee: University of Florida Research Foundation, Inc.
    Inventor: Franky So
  • Patent number: 8298835
    Abstract: The present invention identifies biomarkers that are diagnostic of nerve cell injury, organ injury, and/or neuronal disorders. Detection of different biomarkers of the invention are also diagnostic of the degree of severity of nerve injury, the cell(s) involved in the injury, and the subcellular localization of the injury.
    Type: Grant
    Filed: June 11, 2008
    Date of Patent: October 30, 2012
    Assignee: University of Florida Research Foundation, Inc.
    Inventors: Ka-Wang (Kevin) Wang, Ming Chen Liu
  • Patent number: 8300330
    Abstract: Disclosed is a lens driving apparatus. The lens driving apparatus includes a base formed at a center thereof with a first opening; a housing coupled with the base and having a second opening corresponding to the first opening; a yoke installed on the base and including a horizontal plate having a third opening corresponding to the first opening and a vertical plate protruding upward from the horizontal plate; a bobbin movably installed in the yoke and coupled with a lens module; a coil fixedly disposed around the bobbin; a plurality of magnets provided at the vertical plate of the yoke to face the coil; and a spring installed on at least one of upper and lower portions of the yoke to return the bobbin, which has moved up due to interaction between the magnet and the coil, to its initial position.
    Type: Grant
    Filed: November 22, 2011
    Date of Patent: October 30, 2012
    Assignee: LG Innotek Co., Ltd.
    Inventors: Sang Ok Park, Sang Jun Min, Sang Hee Lee
  • Patent number: 8298818
    Abstract: The present inventors concerns vectors carrying a truncated chimeric CMV-chicken ?-actin (smCBA) promoter in which the hybrid chicken ?-actin/rabbit ?-globin intron is greatly shortened, and their use to deliver to an operatively linked polynucleotide to host cells in vitro or in vivo, resulting in expression of the polynucleotide in the host cells. In one embodiment, the vector carrying the smCBA promoter is administered to the eye. In another embodiment, the vector carrying the smCBA promoter is a self-complementary adeno-associated virus (AAV). The AAV vector may be of any serotype (e.g., type 1, type 2, type 3, type 4, type 5, type 6, type 7, type 8, type 9, type 10). In another embodiment, a self-complementary vector carrying the smCBA promoter is administered to the eye. Another aspect of the invention concerns host cells carrying a vector of the invention.
    Type: Grant
    Filed: April 27, 2007
    Date of Patent: October 30, 2012
    Assignee: University of Florida Research Foundation, Inc.
    Inventors: Sanford Leon Boye, William W. Hauswirth, Barry John Byrne
  • Patent number: 8298134
    Abstract: The dilation balloon of the subject invention preferably comprises a balloon portion mounted about a shaft that, when inflated, produces a configuration comprising a tapered distal end and a proximal end or butt that is substantially flat (preferably truncated) and is adapted to generally conform with the outer contours of an endoscope through which it is introduced when the balloon is pulled back against the endoscope face. The close engagement of the subject balloon catheter and endoscope, when forming a balloon-scope train, enables the scope to more readily navigate strictures and tortuous body lumen, as well as allows the balloon to act as a lens for viewing anatomical structure within the body lumen, such as tumors, strictures, and the inner luminal wall surface itself.
    Type: Grant
    Filed: August 31, 2005
    Date of Patent: October 30, 2012
    Assignee: University of South Florida
    Inventor: James S. Barthel
  • Patent number: 8298762
    Abstract: The present invention provides methods, nucleic acids and molecular markers for the characterization of cells, tissues and heterogeneous mixtures of cells. Specifically, it describes particular genes and genomic regions in which DNA methylation patterns are a consistent and characteristic property of different cell types, states and stages of differentiation. The invention is useful in determining the identity, composition, quality and potency of cells and cell populations. Furthermore, the invention will be useful in monitoring the differentiation of cells.
    Type: Grant
    Filed: March 13, 2006
    Date of Patent: October 30, 2012
    Assignee: Epiontis GmbH
    Inventors: Sven Olek, Ivana Türbachova, Paul Gardina
  • Patent number: 8294312
    Abstract: Provided is a sintered bearing with oil for a spindle motor. The bearing is characterized in that at least one portion of upper and lower sides of the bearing is denser than other portions of the bearing.
    Type: Grant
    Filed: August 21, 2007
    Date of Patent: October 23, 2012
    Assignee: LG Innotek Co., Ltd.
    Inventors: Chung Hyun Song, Tae Wook Lee
  • Patent number: 8293797
    Abstract: The subject invention relates in part to the oral administration of ecdysteroids for controlling subterranean termites. Preferred ecdysteroids for use according to the subject invention are ecdysone, certain ecdysone analogs, and 20-hydroxyecdysone, for example. In some preferred embodiments, one or more of these compounds is used in a termite bait in combination with one or more chitin synthesis inhibitors. Thus, the subject invention also relates in part to controlling termites by the use of a chitin synthesis inhibitor (CSI), such as hexaflumuron and/or noviflumuron, together with an ecdysteroid (and analogs thereof) or molt-accelerating compound (MAC), such as halofenozide. The subject invention also relates to mixtures comprising these two active ingredients. The MAC/ecdysteroid analog induces a preliminary molting event in termite workers (they could not complete the molting), which then allows the CSI to further disrupt the molt and cause mortality.
    Type: Grant
    Filed: April 8, 2011
    Date of Patent: October 23, 2012
    Assignee: University of Florida Research Foundation, Inc.
    Inventors: Nan-Yao Su, James Edward King, Paul Allen Neese
  • Patent number: 8293717
    Abstract: The subject invention concerns a method of inhibiting an RNA virus infection within a patient by increasing the amount of 2-5 oligoadenylate synthetase (2-5 AS) activity within the patient. Preferably, the preventative and therapeutic methods of the present invention involve administering a nucleotide encoding 2-5 AS, or at least one catalytically active fragment thereof, such as the p40, p69, p100 subunits, to a patient in need thereof. The present inventors have determined that overexpression of 2-5AS causes a reduction in epithelial cell damage, reduction in infiltration of mononuclear cells in the peribronchiolar and perivascular regions, and reduction in thickening of the septa in the lungs. Levels of chemokines, such as MIP1-?, are also reduced upon overexpression of 2-5AS. The subject invention also pertains to pharmaceutical compositions containing a nucleotide sequence encoding 2-5 AS and a pharmaceutically acceptable carrier, as well as vectors for delivery of the 2-5 AS nucleotide sequence.
    Type: Grant
    Filed: December 15, 2009
    Date of Patent: October 23, 2012
    Assignee: University of South Florida
    Inventors: Shyam S. Mohapatra, Aruna K. Behera
  • Patent number: 8296015
    Abstract: A method and apparatus of determining a straight-driving state or a turning state of a moving object using an acceleration sensor are provided. The method of determining a turning state using a sensor includes: reading sensor output signals of different axes from an acceleration sensor while a moving object is being driven wherein the acceleration sensor is an at least two axes acceleration sensor and detects an acceleration of the moving object; and comparing the read sensor output signals of the different axes and determining whether the moving object is in a straight-driving state or in a turning state.
    Type: Grant
    Filed: June 25, 2007
    Date of Patent: October 23, 2012
    Assignee: Thinkware Systems Corporation
    Inventors: Kwon Soo Lee, Yong Kwan Park
  • Patent number: 8296483
    Abstract: Provided is a storage device of a serial attached small computer system interface/serial advanced technology attachment (SAS/SATA) type, which provides data storage/reading services through an SAS/SATA interface. The SAS/SATA type storage device includes: a memory disk unit which includes a plurality of memory disks provided with a plurality of volatile semiconductor memories; an SAS/SATA host interface unit which interfaces between the memory disk unit and a host; and a controller unit which adjusts synchronization of a data signal transmitted/received between the SAS/SATA host interface unit and the memory disk unit to control a data transmission/reception speed between the SAS/SATA host interface unit and the memory disk unit.
    Type: Grant
    Filed: November 29, 2009
    Date of Patent: October 23, 2012
    Assignee: Taejin Info Tech Co., Ltd.
    Inventor: Byungcheol Cho
  • Patent number: 8292175
    Abstract: Embodiments relate to a tag device, a reader device, and a radio frequency identification (RFID) system. The Q embodiment provides a tag device comprising: a reception module converting a received high frequency signal into a scale level, and Q converting the converted scale level into a digital signal to output the same; a transmission module modulating a transmission signal M to output the same; and a controller controlling the reception module and the transmission module. The tag device communicates with the reader device through wireless short distance communication.
    Type: Grant
    Filed: June 9, 2008
    Date of Patent: October 23, 2012
    Assignee: LG Innotek Co., Ltd.
    Inventor: Nam Yun Kim
  • Patent number: 8293237
    Abstract: This invention provides binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind a CD154 (CD40L) protein. This invention also provides a chimeric, humanized or fully human antibody, antibody derivative or antibody fragment that specifically binds to an epitope to which a humanized Fab fragment comprising a variable heavy chain sequence according to SEQ ID NO: 1 and comprising a variable light chain sequence according to SEQ ID NO: 2 specifically binds. CD154 binding proteins of this invention may elicit reduced effector function relative to a second anti-CD154 antibody. CD154 binding proteins of this invention are useful in diagnostic and therapeutic methods, such as in the treatment and prevention of diseases including those that involve undesirable immune responses that are mediated by CD154-CD40 interactions.
    Type: Grant
    Filed: March 21, 2008
    Date of Patent: October 23, 2012
    Assignees: UCB Pharma, S.A., Biogen Idec MA Inc.
    Inventors: Linda C. Burkly, Janine L. Ferrant-Orgettas, Ellen A. Garber, Yen-Ming Hsu, Lihe Su, Frederick R. Taylor, Ralph Adams, Derek Thomas Brown, Andrew George Popplewell, Martyn Kim Robinson, Anthony Shock, Kerry Louise Tyson
  • Patent number: 8288398
    Abstract: The present invention is related to a novel series of pyrimidyl or fused pyrimidyl hydrazones. Compounds of Formula (I) wherein A is selected from the group consisting of Formulas (A1), (A2), (A3), (A4), (A5) are useful for the treatment and/or prevention of a proliferative disease.
    Type: Grant
    Filed: December 8, 2006
    Date of Patent: October 16, 2012
    Assignee: Merck Serono SA
    Inventors: Brian Healey, Zhong Zhao, Amanda Sutton, Matthias Schwarz
  • Patent number: 8288091
    Abstract: The present invention relates to the identification of a novel mechanism of transcription infidelity in cells. The invention provides compositions and methods to detect the level of transcript ion infidelity in a sample, as well as the use thereof, e.g., for therapeutic, diagnostic, pharmacogenomic or drug design. As will be disclosed, the invention is particularly suited for detecting, monitoring or treating proliferative cell disorders, for the design and/or screening of drugs, for patient or disease profiling, prediction of disease severity and evaluation of drug efficacy.
    Type: Grant
    Filed: July 20, 2007
    Date of Patent: October 16, 2012
    Assignee: Transmedi SA
    Inventor: Bernard Bihain
  • Patent number: 8288107
    Abstract: The subject invention concerns materials and methods for detecting the interaction of CFTR proteins. In one embodiment, the method can be used to determine whether one CFTR polypeptide interacts with a second CFTR polypeptide. The subject invention also concerns materials and methods for screening for drugs or compositions that can restore or enhance interaction of CFTR proteins containing mutation(s) that reduce or prevent dimerization of the proteins. The assay of the present invention can be used to screen a large number of compounds in a high throughput format. The subject invention also pertains to host cells useful in the methods of the invention. The subject invention also concerns compositions and methods for treating patients afflicted with cystic fibrosis.
    Type: Grant
    Filed: June 25, 2007
    Date of Patent: October 16, 2012
    Assignee: Florida State University Research Foundation
    Inventor: John L. Teem
  • Patent number: 8288432
    Abstract: The present invention is related to tetrahydroindole derivatives of Formula (I), pharmaceutical composition thereof, methods of preparation thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Grant
    Filed: March 28, 2008
    Date of Patent: October 16, 2012
    Assignee: Genkyotex SA
    Inventors: Patrick Page, Mike Orchard, Laetitia Fioraso-Cartier, Bianca Mottironi
  • Patent number: 8284787
    Abstract: The subject invention provides a data structure and method for IP lookups, insertions, and deletions using a dynamic tree bitmap structure (DTBM) that utilizes an array of child pointers for each node instead of the typical TBM approach using one pointer to an array of children.
    Type: Grant
    Filed: July 20, 2007
    Date of Patent: October 9, 2012
    Assignee: University of Florida Research Foundation, Incorporated
    Inventors: Sartaj Kumar Sahni, Haibin Lu
  • Patent number: 8284473
    Abstract: A dual active electrochromic device is a combination of at least two working electrodes that contain electrochromic materials and at least one counter electrode where the potentials between each working electrode and a counter electrode are independently supplied. No more than one electrode is reflective. The color of the device results from the additive color of the electrochromic materials and varies according to the potentials applied independently. The electrochromic materials can be electrochromic polymers that are deposited as film on substrates to form the working electrodes. The electrochromic device can be used for display or window applications.
    Type: Grant
    Filed: March 24, 2009
    Date of Patent: October 9, 2012
    Assignee: University of Florida Research Foundation, Inc.
    Inventors: John R. Reynolds, Aubrey Lynn Dyer, Ece Unur